Scarica l'app Stockscreener
5.15
16.67%
-1.03
Pre-mercato:
5.14
-0.01
-0.19%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché SONN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.18
Aprire:
$6.27
Volume 24 ore:
1.65M
Relative Volume:
0.47
Capitalizzazione di mercato:
$16.30M
Reddito:
$129.20K
Utile/perdita netta:
$-7.44M
Rapporto P/E:
-0.4602
EPS:
-11.19
Flusso di cassa netto:
$-8.62M
1 W Prestazione:
-46.58%
1M Prestazione:
+332.77%
6M Prestazione:
+234.42%
1 anno Prestazione:
-24.26%
Intervallo 1D:
$5.15
$6.40
Intervallo di 1 settimana:
$5.15
$10.38
Portata 52W:
$1.08
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
Nome
Sonnet Biotherapeutics Holdings Inc
Settore
Industria
Telefono
609-375-2227
Indirizzo
100 OVERLOOK CENTER, PRINCETON, NJ
Confronta SONN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
5.15 | 30.52M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Sonnet Biotherapeutics Holdings Inc Borsa (SONN) Ultime notizie
What analysts say about Sonnet BioTherapeutics Holdings Inc. stockDouble or triple returns - jammulinksnews.com
Is Sonnet BioTherapeutics Holdings Inc. a good long term investmentExplosive earnings growth - Autocar Professional
What drives Sonnet BioTherapeutics Holdings Inc. stock priceDynamic profit opportunities - jammulinksnews.com
Sonnet BioTherapeutics Holdings Inc. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com
Halper Sadeh investigates Sonnet BioTherapeutics, First Community Corp, Monogram Technologies mergers. - AInvest
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders - GlobeNewswire Inc.
Biotech Minnow Sonnet Takes A Hard Turn Into Crypto - Finimize
Sonnet BioTherapeutics Secures Funding to Meet Nasdaq Requirements - TipRanks
Sonnet BioTherapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of SON-1010 for Advanced Solid Tumors - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Sonnet BioTherapeutics Bets Big on HYPE Token as Charts Signal 161% Rally Potential - CoinChapter
Sonnet BioTherapeutics’ New Strategy with $888 Million Worth of Crypto Reserves! - Pintu
Sonnet BioTherapeutics Launches $583 Million Crypto Treasury With HYPE Token - AInvest
Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price - Cointelegraph
Sonnet BioTherapeutics Announces $888M Combination With Rorschach For HYPE Treasury - Tekedia
Biotech Firm Sonnet Pivots to Crypto Treasury Strategy in $888M HYPE Token Deal - blockhead.co
Best Biotech Stocks Worth Watching – July 14th - Defense World
What makes Sonnet BioTherapeutics Holdings Inc. stock price move sharplyVerified Return Tips - Newser
$888M Crypto Pivot: Nasdaq Biotech Firm Goes All-In on HYPE Token with Bold Treasury Bet - CryptoNinjas
Why Sonnet BioTherapeutics Holdings Inc. stock attracts strong analyst attentionHigh Probability Setups - Newser
How Sonnet BioTherapeutics Holdings Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
Sonnet BioTherapeutics Launches $888M Crypto Treasury Strategy - The Crypto Times
Sonnet BioTherapeutics Announces Merger with Rorschach I LLC - The Globe and Mail
Crypto Deal Boosts Sonnet BioTherapeutics Share Price By 260% - Happy Coin News
Sonnet BioTherapeutics Merges in $888M Deal to Launch Hyperliquid Strategies and HYPE Treasury - The Currency analytics
PLTR, TTD, TLRY, SONN, TSLA: 5 Trending Stocks TodaySonnet BioTherapeutics (NASDAQ:SONN), Palantir Technologies (NASDAQ:PLTR) - Benzinga
Hyperliquid's Price Drops 2.82% Amid Nasdaq Listing Through Sonnet BioTherapeutics Merger - AInvest
Small Healthcare Stocks Enjoy Big Wins On Deal News - Finimize
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - Stocktwits
Sonnet BioTherapeutics Holdings Inc (SONN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Atlas Merchant Capital LLC entered into a definitive agreement to acquire Sonnet BioTherapeutics Holdings, Inc. in a reverse merger transaction. - MarketScreener
Massive deal sends biotech stock rallying 367% - Yahoo Finance
Sonnet BioTherapeutics Agrees $888M Merger as It Launches Strategic HYPE Treasury - NFTgators
Hyperliquid Strategies Inc. to Hold $583 Million in HYPE Tokens Post Merger - AInvest
New Nasdaq-Listed Company, Hyperliquid Strategies, to Hold $583M in HYPE Tokens - CryptoRank
Crude Oil Moves Lower; Daré Bioscience Shares JumpDiginex (NASDAQ:DGNX), Dare Bioscience (NASDAQ:DARE) - Benzinga
Sonnet Biotherapeutics shares surge 59.85% intraday after announcing an $888 million business combination to launch a HYPE cryptocurrency treasury reserve strategy. - AInvest
HYPE coin price up 200%, Sonnet BioTherapeutics merges into Hyperliquid Strategies - Invezz
Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday? - Benzinga
Sonnet ditches biotech dreams to anchor a $583m HYPE token reserve - Crypto News
Sonnet BioTherapeutics Merges with Rorschach I to Form Hyperliquid Strategies Inc. Stock Surges 200% - AInvest
Sonnet BioTherapeutics Spikes 153% on $888 Million Deal with Rorschach - Wall Street Pit
Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):